-
Navigating Uncharted Waters: Challenge of Anticipating Technologies Subject to Environmental Considerations in Future HTA
Sep 9, 2025, 16:22 PM -
Resource Utilization Among Patients With Epidermolysis Bullosa: Preliminary Findings From Seven European Countries
Sep 9, 2025, 16:22 PM -
What Are the Impacts of the Absence of Health Economic Evaluations for Drugs Granted an ASMR IV Rating by the French National Authority of Health (HAS)? An Analysis of Medicines Assessed Between May 2022 and May 2024
Sep 9, 2025, 16:22 PM -
EQ-5D Utility Impact of Worsening NYHA Class and CV Hospitalization (CVH) on Health-Related Quality of Life (HRQoL) of Patients With ATTR-CM Based on the ATTRibute-CM Trial
Sep 9, 2025, 16:22 PM -
EU HTA JCA PICO Consolidation Process Examples: Key Trends and Remaining Uncertainties
Sep 9, 2025, 16:22 PM -
Comparative Efficacy of Ongericimab Versus Six PCSK9 Inhibitors in Treating Hypercholesterolemia or Mixed Dyslipidemia: A Network Meta-Analysis
Sep 9, 2025, 16:22 PM -
Navigating HTA Requirements: The Current Landscape of Alzheimer's Disease-Modifying Treatments
Sep 9, 2025, 16:22 PM -
Literature Review on the Economic Impact of Maternal Fetal Infections
Sep 9, 2025, 16:22 PM -
Model Structure Variability in NICE HTAs: Evidence From Asthma and TMA Appraisals to Support the Need for Disease-Specific Reference Models
Sep 9, 2025, 16:22 PM -
Ai-Augmented Data Extraction in Literature Reviews: Toward First-Pass Accuracy Competitive With Human Performance
Sep 9, 2025, 16:22 PM -
Incorporating Environmental Impact Into Health Economic Evaluations: A Review of Methodological Approaches and Practical Applications
Sep 9, 2025, 16:22 PM -
A Novel Framework to Assess Noninferiority in National Institute for Health and Care Excellence (NICE) Cost-Comparison Evaluations (CCEs) Where Network Meta-Analyses (NMAs) Report Nonstatistically Significant Differences
Sep 9, 2025, 16:22 PM -
Distributional Cost-Effectiveness Analysis Across the Globe: How Feasible Is It Really?
Sep 9, 2025, 16:22 PM -
How Far Have We Come With EQ-5D-5L Value Sets? An Updated Systematic Literature Review of 55 Valuation Studies
Sep 9, 2025, 16:22 PM -
Studying Paternal Drug Exposures and Offspring Outcomes: A Feasibility Assessment of 11 Large European Databases
Sep 9, 2025, 16:22 PM -
A Budget Impact Model of Switching From Self-Monitoring of Blood Glucose to Continuous Glucose Monitoring for Individuals With Type 2 Diabetes Mellitus Receiving Basal Insulin in Italy
Sep 9, 2025, 16:22 PM -
The Impact of the Introduction of Diagnosis-Related Groups (DRG)-Based Hospital Financing on the Performance of Romanian Hospitals
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Synovial Biopsy-Guided Treatment Strategy After TNF-Alpha Inhibitor Failure in Rheumatoid Arthritis
Sep 9, 2025, 16:22 PM -
Beyond the Guidelines: Exploring the Characteristics and Comorbidity Profiles of Adults With Pneumococcal Disease in England Not Covered by Current Pneumococcal Vaccination Criteria
Sep 9, 2025, 16:22 PM -
US PIE and AMCP Dossiers: Payer Preferences Best Practice and a Comparison With Global Evidence Dossiers
Sep 9, 2025, 16:22 PM
